Clinical trialNCT00624234CompletedInterventional

Neurobiology and Treatment of Reading Disability in NF-1

SponsorVanderbilt UniversityEnrollment184Neurofibromatosis Type 1Reading Disabilities

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this trial is to determine if children with neurofibromatosis type 1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs as children with idiopathic reading disabilities do, and to determine which intervention is best for particular learner profiles.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Gore, Ph.D.
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗
Laurie E. Cutting, Ph.D.
Vanderbilt University Special Education Department
Principal Investigator
clinicaltrials.gov ↗
Martha Bridge Denckla, M.D.
Kennedy Krieger Institute, Johns Hopkins University, Johns Hopkins University School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Sheryl L. Rimrodt, M.D.
Vanderbilt University Pediatrics Department
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Vanderbilt University, Vanderbilt University Institute of Imaging Science
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 28 Feb 2006
Primary completion: 31 Mar 2013
Completion: 31 Jan 2017
Last update posted: 8 Jul 2025
Registered enrollment: 184
Registry id: NCT00624234

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.